Stay updated on Viatris Press Releases

Sign up to get notified when there's something new on the Viatris Press Releases page.
Latest website image capture
Clouds background image

Latest updates to the Viatris Press Releases page

  1. Check
    7 days ago
    Change Detected
    Summary
    Added: Viatris to Report First Quarter 2026 Financial Results on May 7, 2026. Deleted: Viatris Appoints Lara Ramsburg as Chief People and Corporate Affairs Officer (Jan 8, 2026).
    Difference
    6%
    Check dated 2026-04-18T03:58:35.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    Added a new press release entry for Apr 10, 2026 about multiple data presentations at the 2026 ASCRS Annual Meeting. Removed the Dec 18, 2025 press release about four regulatory milestones.
    Difference
    7%
    Check dated 2026-04-10T22:45:57.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    Change Detected
    Summary
    Added a new press release on Mar 23, 2026 about Effexor® approval in Japan for adults with GAD; removed the Dec 17, 2025 press release about presenting at the JP Morgan Healthcare Conference.
    Difference
    7%
    Check dated 2026-03-27T13:30:34.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    A new press release entry dated Mar 19, 2026 was added to the Press Releases page; an older release about monetizing its Biocon Biologics stake was removed.
    Difference
    7%
    Check dated 2026-03-20T07:35:22.000Z thumbnail image
  6. Check
    57 days ago
    Change Detected
    Summary
    New press releases were added for Feb 26, 2026: Viatris’ Fourth-Quarter and Full-Year 2025 Financial Results and the Dividend Policy for 2026; and Feb 25, 2026: FDA accepts the NDA for MR-141. Older November 2025 press releases were removed from the list.
    Difference
    8%
    Check dated 2026-02-26T14:50:33.000Z thumbnail image
  7. Check
    79 days ago
    Change Detected
    Summary
    Two new press releases were added: Viatris to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026, and Viatris Appoints Matthew J. Maletta as Chief Legal Officer. Two older items were removed: Viatris Announces Quarterly Dividend and Viatris Completes Acquisition of Aculys Pharma Including Exclusive Rights to Pitolisant in Japan and to Spydia® in Japan and Certain Other Markets in the Asia-Pacific Region.
    Difference
    7%
    Check dated 2026-02-04T23:29:55.000Z thumbnail image

Stay in the know with updates to Viatris Press Releases

Enter your email address, and we'll notify you when there's something new on the Viatris Press Releases page.